# A Pilot Study of Neoadjuvant Therapy With Gemcitabine and Cisplatin in Patients With Resectable or Unresectable Intrahepatic Cholangiocarcinoma

> **NCT02256982** · NA · TERMINATED · sponsor: **Massachusetts General Hospital** · enrollment: 3 (actual)

## Conditions studied

- Unresectable Intrahepatic Cholangiocarcinoma
- Resectable Intrahepatic Cholangiocarcinoma

## Interventions

- **DRUG:** Gemcitabine
- **DRUG:** Cisplatin
- **PROCEDURE:** Surgery
- **RADIATION:** Radiation

## Key facts

- **NCT ID:** NCT02256982
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-10
- **Primary completion:** 2016-03
- **Final completion:** 2016-03
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** Slow accrual.
- **Last updated:** 2016-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02256982

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02256982, "A Pilot Study of Neoadjuvant Therapy With Gemcitabine and Cisplatin in Patients With Resectable or Unresectable Intrahepatic Cholangiocarcinoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02256982. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*